Altis Biosystems
Developer of a stem cell technology designed to recreate the human intestinal epithelium and colonic epithelium for compound screening and microbiome research. The company's technology produces a laye...
Valuation
$20M
Market implied
Share Price
N/A
Total Raised
$8.8M
Last Round
N/A